-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOGEN SHARES DOWN 6.2% AFTER CO'S EXPERIMENTAL ALZHEIMER'S DRUG MISSES MAIN GOAL IN MID-STAGE STUDY

Reuters·07/14/2026 13:38:50

Please log in to view news